Inteliview
Log inSign up
IPO Tracker
BlossomHill Therapeutics, Inc.

BlossomHill Therapeutics, Inc.

BlossomHill Therapeutics, Inc.

USPricing
Valuation$100M
Original Target2026-07-17 (Date under review)
Sector--
Exchange--
RELATED IPOS
RanMarine Technology B.V.
RanMarine Technology B.V.RanMarine Technology B.V.US · --
GridAI Technologies Corp.
GridAI Technologies Corp.GridAI Technologies Corp.US · --
FreeCast, Inc.
FreeCast, Inc.FreeCast, Inc.US · --
APEX Global Solutions Ltd
APEX Global Solutions LtdAPEX Global Solutions LtdUS · --
HCW Biologics Inc.
HCW Biologics Inc.HCW Biologics Inc.US · --
Creatd, Inc.
Creatd, Inc.Creatd, Inc.US · --
FAQ

When is the BlossomHill Therapeutics, Inc. IPO expected?

The BlossomHill Therapeutics, Inc. IPO is currently in the Pricing stage. The originally expected date was 2026-07-17 and the process is ongoing. Timelines may change based on market conditions.

What is BlossomHill Therapeutics, Inc.'s valuation?

BlossomHill Therapeutics, Inc.'s estimated valuation is approximately $100M. The final valuation will depend on IPO pricing and market demand.

Can retail investors participate in the BlossomHill Therapeutics, Inc. IPO?

U.S. IPOs are typically allocated to institutional investors first. Retail investors can purchase shares on NYSE/NASDAQ after listing. Some brokerages offer IPO access programs for pre-IPO allocation.